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Echinococcus multilocularis, the causative agent of human
alveolar echinococcosis, is reported for the first time in Red
Foxes (Vulpes vulpes) in Hungary. This parasite may be spread-
ing eastward because the population of foxes has increased as
a consequence of human interventions, and this spread may
result in the emergence of alveolar echinococcosis in Central
Eastern Europe. 
E
chinococcus multilocularis is the causative agent of alveo-
lar echinococcosis in humans. The life cycle of this tape-
worm is indirect and sylvatic; eggs shed by the definitive host,
mainly the Red Fox (Vulpes vulpes) in Europe, develop to the
metacestode stage in arvicolid rodents, which serve as interme-
diate hosts. In accidental cases, humans as aberrant intermedi-
ate hosts may also acquire E. multilocularis infection by egg
ingestion. Although a rare disease in humans, alveolar
echinococcosis is of considerable public health importance
because it can be lethal in up to 100% of untreated patients (1).
Treatment is still difficult, and therapy may cost $300,000 per
patient (1).
The parasite has an extensive geographic distribution in
the Northern Hemisphere, including parts of North America
(Alaska, Canada, and some of the lower contiguous states of
the United States), Asia (some of the newly independent states
of the former Soviet Union, China, and Japan), and some
European countries. Until the end of the 1980s, parasite-
endemic areas in Europe were known to exist only in France,
Switzerland, Germany, and Austria (2). In the 1990s and early
2000s, the infection rate of foxes increased drastically in some
areas of France and Germany; several new endemic foci were
detected in Switzerland, Germany, and Austria; and the parasite
was reported from the surrounding countries, including The
Netherlands, Belgium, Luxembourg, Poland, the Czech
Republic, the Slovak Republic, and Italy (1,3,4). Here we
report E. multilocularis infection from Red Foxes in the north-
ern areas of Hungary and give a possible explanation for the
spreading of the parasite from the west to the east.
Carcasses of Red Foxes sent to the Central Veterinary
Institute, Budapest, from January to July 2002, in connection
with the rabies immunization and control program, were
included in this study. Carcasses were transported and stored in
individual plastic bags at 4°C. The approximate delay between
death and necropsy was 2 days. We examined the intestinal
tracts by the sedimentation and counting technique as described
(5). The whole sediment was examined in petri dishes under
stereomicroscope at a magnification of X66, and worms were
ascertained, counted, and subsequently washed and stored in
70% ethanol until DNA purification. Of 100 foxes (18
subadults and 82 adults) examined during the screening of the
parasitologic status of the foxes in 15 counties in Hungary, 5
adults shot in April and May 2002 were found to be infected
with 2, 3, 5, 6, and 254 mature worms of Echinococcus, respec-
tively (Figure 1). 
All five foxes were shot in two northern Hungarian coun-
ties, Nógrád and Borsod-Abaúj-Zemplén, in the Nógrád Basin
(Drégelypalánk, 48°02' North, 19°04' East, and Pusztaberki,
47°58' North, 19°11' East), in the Cserhát Mountains
(Salgótarján, 48°03' North, 19°47' East and 48°01' North,
19°45' East) and in the Borsod Basin (Kelemér, 48°19' North,
20°27' East), near the Hungarian-Slovak border. The five
places are in the Northern Mountain Range and at a distance of
60–120 km from the nearest known E. multilocularis–endemic
region, the Muránska Planina Mountains (48°44' North, 20°02'
East) in Slovakia (6). These territories are 200–400 m above
sea level and are mainly forested, nonagricultural, or extensive
agricultural areas. Based on the most important morphometric
parameters of Echinococcus adult stages (length of the worm:
1.3–2.5 mm; number of proglottids: 3–5; length of terminal
proglottids: 0.5–1.1 mm; terminal proglottids in percentage of
total worm length: 26–44; position of genital pore: anterior to
middle; form of uterus: sacklike without lateral sacculations),
the parasites were identified as E. multilocularis (7). Although
the overall prevalence of E. multilocularis seems to be low in
Hungary, in the two E. multilocularis–endemic counties, the
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Figure 1. Echinococcus multilocularis isolated from a fox in Hungary.
Scale bar: 0.5 mm.prevalence was considerably higher (5 of 17 foxes were infect-
ed). These prevalence data are similar to those observed in the
surrounding countries, Austria and The Slovak Republic (8,9).
The taxonomic status of the isolates was also confirmed by
a diagnostic polymerase chain reaction (PCR) assay. The five
isolates were treated separately. Two different genes coding for
U1 snRNA and the mitochondrial 12S rRNA genes have been
used in diagnostic PCR for detecting E. multilocularis DNA
(10–12); however, the species specificity of the PCR amplify-
ing a fragment of the U1 snRNA gene could not be confirmed
in a study (12). Thus, the nested PCR method described by
Dinkel et al. (11) was used in our study. To exclude the possi-
bility of contamination with specific DNA, a negative control
was included and underwent the entire procedure starting with
DNA extraction. DNA was purified as described (13). PCR
reactions were performed by using a GeneAmp 2400 PCR sys-
tem (Perkin Elmer, Foster City, CA). The conditions used for
PCR were identical to those described (12). PCR products were
detected on ethidium bromide–stained 1.5% agarose gels by
visualizing them with UV light. PCR products of the expected
size (373 bp and 250 bp) were amplified in all cases (Figure 2),
confirming the results of the morphologic comparisons, i.e., E.
multilocularis was responsible for all infections.
According to some authors (1,2), researchers cannot con-
firm whether E. multilocularis is spreading from historically
known E. multilocularis–endemic foci (eastern France, south-
ern Germany, northern Switzerland, and western Austria) to
new regions, or whether the Central European E. multilocu-
laris–endemic area is connected with the E. multilo-
cularis–endemic area in Asia, and the tiny worms previously
escaped the attention of parasitologists. Our findings may sug-
gest that the parasite’s range has recently expanded, rather than
the first identification of formerly unknown E.
multilocularis–endemic areas. The parasite was not identified
previously in either Red Foxes or wild rodents in Hungary,
despite the extensive studies conducted by Murai, Mészáros,
Gubányi, and other parasitologists of the Natural History
Museum, Budapest. Moreover, human cases have never been
reported in Hungary. The photograph and the description of
macroscopic lesions (two fist-sized, undulating cysts) in the
only presumed report of alveolar echinococcosis written by two
surgeons (14) clearly indicate that the case was indeed cystic
echinococcosis.
The appearance of E. multilocularis in Hungary might be
explained by changes in the size of the Red Fox population in
Central and Central Eastern Europe. From the 1970s, a contin-
uous increase in the size of the Red Fox population was
observed in Switzerland and Germany, probably as a conse-
quence of the initiation of the antirabies vaccination programs
(2). The larger population led to a continuous migration of
young foxes from territories with high population density
toward those with lower density, i.e., partly eastward. This
migration might have resulted in the appearance of foxes
infected with E. multilocularis and the establishment of small
disease-endemic foci in Poland and the Czech Republic. After
the political changes of 1990, considerable changes in land use
were observed in the former communist countries because of
the disintegration of large state farms. The probable conse-
quences of these changes, the decrease of annual hunting index
resulting from a decrease in the price of fox fur, and the initia-
tion of antirabies vaccination of foxes in Central Eastern
European countries (Poland, the Czech Republic, the Slovak
Republic, and Hungary), caused a corresponding increase in
the fox population size (8,15), and probably the coincidental
increase of E. multilocularis population and prevalence, and
the expansion of E. multilocularis–endemic regions. A similar
positive correlation between the population size of foxes and
the prevalence of the parasite was also observed in Switzerland
and Germany (2). 
In the historically known E. multilocularis–endemic
region, almost 400 patients are currently under continuous ther-
apy, and the annual incidence of human alveolar echinococco-
sis has not varied markedly in the past few decades (1,2). In
contrast with the stable epidemiologic situation in that region,
the first 16 sufficiently documented and undoubtedly con-
firmed autochthonous human infections have been reported in
Central Eastern European countries only from the late 1990s
(2,9). Based on Central European annual incidence data
(approximately 0.1–0.3/100,000 population) (2) and the similar
overall prevalence of infection in foxes in Central and Central
Eastern European countries (2,9), hundreds of cases would
have been expected in the past few decades. The tiny worms
may have escaped the attention of Central Eastern European
parasitologists earlier. However, failing to recognize the charac-
teristic and extensive lesions in humans in the past is unlikely.
Data from The Netherlands, Italy, Hokkaido Island and the
surrounding islands of Japan, and North America provide clear
evidence for the spreading and emergence of E. multilocularis
infection (2,4,12). In the past, E. multilocularis has spread from
the tundra zone of Northern Canada to the central regions of the
continental United States (7) and from a small focus to the
entire Hokkaido Island (2). Based on the above data, a similar
spreading and emergence are likely being observed in Central
Eastern European countries. As a result of their increasing pop-
ulation, foxes are inhabiting urban areas in several European
countries, including Hungary (1,15). The appearance of foxes
in a synanthropic environment may result in the infection of
Emerging Infectious Diseases • Vol. 9, No. 3, March 2003 385
DISPATCHES
Figure 2. Nested polymerase chain reaction amplification of mitochon-
drial 12S rRNA gene from five Hungarian Echinococcus multilocularis
isolates. Lanes A-E: amplification with outer primers; lanes F-J: amplifi-
cation with inner primers; N, appropriate negative controls; M, molecu-
lar weight marker (100 bp).domesticated dogs and cats and may increase the risk for
human infections in E. multilocularis–endemic areas. Thus,
knowing that E. multilocularis is likely to continue to spread,
one can predict that human alveolar echinococcosis will
become an emerging infectious disease in Central Eastern
European countries in a few years as has already occurred in
some other European countries, Hokkaido Island of Japan,
Canada, and the United States (2,4,12,16).
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